Welcome to The QUEST Initiative
The QUality of life Evaluation STudy (QUEST Initiative), conducted by researchers at the University of Sydney, aims to be the world’s largest longitudinal clinical study investigating the quality of life and health economic impact of cannabinoid therapy on patients with chronic disease.
Patients accessing cannabinoid therapy generally have a range of conditions and symptoms that impact their quality of life. This clinical study sets out to better understand and measure how these conditions and symptoms affect patients’ quality of life over time while they are accessing cannabinoid therapy as a treatment option.
The QUEST Initiative has commenced recruitment of eligible patients.
- Help Advance Medical Research
- Simple Enrolment and Participation
- $150 per bottle plus delivery
- Open to eligible conditions
Why go on this QUEST?
To understand if a ‘new’ medical treatment really works, or if it offers good value for money, we need to be able to measure a person’s health and their response to a treatment. While length of life is easy to measure, quality of life is more subjective, but we can measure it by asking patients questions about different aspects of their health such as their mobility, functionality, pain or discomfort, anxiety and depression. The QUEST Initiative will measure these and other factors through online questionnaires.
The de-identified results from this study will help future patients with certain diagnosed conditions to make better informed decisions about their treatment and understand the potential impact of cannabinoid therapy on their overall quality of life.
